Brief: Chemocentryx And Vfmcrp Announce European Medicines Agency Has Accepted To Review The Marketing Authorization Application For Avacopan

Churchill Capital XI

03/11/2020 14:23

Nov 3 (Reuters) - ChemoCentryx Inc  CCXI.O :
    * CHEMOCENTRYX AND VFMCRP ANNOUNCE EUROPEAN MEDICINES AGENCY
HAS
ACCEPTED TO REVIEW THE MARKETING AUTHORIZATION APPLICATION FOR
AVACOPAN
    * CHEMOCENTRYX INC - EMA APPROVAL IS EXPECTED H2, 2021 FOR
AVACOPAN

Source text for Eikon:  ID:nGNX95crtd 
Further company coverage:  CCXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))